Owens & Minor

Owens & Minor, Inc. engages in the provision of healthcare solutions. It operates through the Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Owens & Minor achieves record revenue, focuses on cost-saving initiatives

Owens & Minor's Q4 2022 performance reflects record revenue, strong segment growth, and strategic initiatives to drive profitability and operational efficiency.
While facing challenges in certain divisions, the company's focus on cost-saving programs and market competitiveness positions it well for future growth and success.
With a positive outlook for 2023, Owens & Minor aims to capitalize on opportunities for growth, cash flow improvement, and market expansion to drive shareholder value.

Owens & Minor reports solid Q1 results, raises 2023 outlook

Owens & Minor's Q1 performance reflects a mix of successes and challenges, with a strong focus on realignment and debt reduction. The company is optimistic about future growth prospects, particularly in the patient direct segment, and remains committed to enhancing operational efficiency and capital deployment.

Owens & Minor reports strong Q2 performance amidst PPE challenges

Owens & Minor's Q2 performance reflects positive momentum with growth in key segments and a focus on financial health through debt reduction.
Challenges in the PPE market and uncertainties in demand highlight the need for strategic planning and risk management strategies.
The company's strengths in revenue growth drivers and new business contracts position it well for future growth opportunities and financial success.

Owens & Minor (OMI) posts strong Q3 results, eyes growth opportunities

Owens & Minor (OMI) reported a solid Q3 performance with revenue growth, debt reduction, and operational efficiency driving financial resilience.
While facing challenges in market visibility and regulatory changes, the company remains well-positioned to capitalize on growth opportunities and enhance shareholder value.
Strategic focus on key segments and profitability improvement initiatives set a positive trajectory for future growth and value creation.
Investors can look forward to sustained performance and profitability as Owens & Minor navigates challenges and seizes growth opportunities in the evolving healthcare landscape.

Owens & Minor (OMI) reports robust Q4 earnings and outlines growth strategy for 2024

Owens & Minor (OMI) showcased strong financial performance in Q4 2023, with a positive outlook for 2024. Despite challenges in EBITDA calculations and deal delays, the company remains focused on strategic investments and operational optimization.

Owens & Minor (OMI) reports robust Q1 performance and growth outlook

Owens & Minor (OMI) delivered strong financial performance in Q1 2024, driven by revenue growth and margin expansion initiatives despite challenges in cash flow and debt reduction.
The company's strategic focus on operational efficiency, cost reduction, and long-term investments positions it well for future growth and market opportunities.
With a solid foundation in place and a clear growth strategy, Owens & Minor (OMI) is poised to navigate challenges and leverage opportunities for sustained success.

Owens & Minor reports revenue growth and strategic acquisitions in Q2

Owens & Minor's Q2 performance showed revenue growth and improved operating income, despite a GAAP net loss.
The acquisition of Rotech Healthcare strengthens the Patient Direct segment, driving revenue growth.
Challenges include managing costs, addressing tariffs' impact, and balancing segment optimization with expansion.
Opportunities exist in leveraging acquisitions, expanding product offerings, and enhancing operational efficiency.

Owens & Minor reports solid Q3 performance and eyes growth

Owens & Minor demonstrated resilience and strategic focus in Q3 2024, with strong financial results and debt reduction achievements.
While facing challenges such as supply chain issues and tariff impacts, the company remains optimistic about growth opportunities.
Investors can look forward to the Rotech acquisition and the company's commitment to operational excellence and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Owens & Minor (OMI) Right Now?

Owens & Minor, Inc. (OMI) Q4 2023 Earnings Call Transcript

Owens & Minor (OMI) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.28 per share a year ago.

Owens & Minor (OMI) Q4 Earnings Surpass Estimates

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023. Full Year 2023 Key Highlights: Consolidated revenue of $10.3 billion Delivered $741 million of operating cash flow Reduced total debt by $403 million and reduced net debt by $577 million Net loss per common share of $(0.54) and adjusted net income per common share of $1.36 “We once again delivered on our commitments and had a strong finish.

Owens & Minor Reports Fourth Quarter and Full Year 2023 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the fourth quarter of 2023 on Tuesday, February 20, 2024, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All int.

Owens & Minor Announces Fourth Quarter 2023 Earnings Release Date and Conference Call

Is Owens & Minor (OMI) Stock Undervalued Right Now?

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor announces the launch of Life Takes Care™, formally recognizing the company's longtime purpose and critical role in healthcare.

Owens & Minor Launches Life Takes Care™

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE-OMI) (the “Company”), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution services and innovative technology, will outline its strategy for delivering and expanding its profitability at its 2023 Investor Day event today in Boston. Details about the event, including instructions for the webcast, are provided below. “We are.

Owens & Minor Unveils Long-Term Strategy at Investor Day Today

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) (the “Company”) today announced that it will host an Investor Day for investors and research analysts on Wednesday, December 6th at Convene in Boston, Massachusetts. The event will feature presentations from members of the senior executive leadership team, who will share the Company's strategic vision, operating and growth strategy, and multi-year financial targets. The event will begin at 8:30 a.m. Eastern Standard Time (EST).

Owens & Minor Announces Upcoming Investor Day on December 6th

Owens & Minor, Inc. (NYSE:OMI ) Q3 2023 Earnings Conference Call November 3, 2023 8:00 AM ET Company Participants Edward Pesicka - President & CEO Alex Bruni - EVP & CFO Jackie Marcus - IR Conference Call Participants Kevin Caliendo - UBS John Stansel - J.P. Morgan Daniel Grosslight - Citi Eric Coldwell - Robert W.

Owens & Minor, Inc. (OMI) Q2 2023 Earnings Call Transcript

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2023. Third Quarter Key Highlights: Consolidated revenue of $2.59 billion Net loss per common share of $(0.08) and adjusted net income per common share of $0.44 $188 million in total debt pay down and $117 million reduction in net debt “Our performance in the third quarter is another strong indication that our business strategy and execution are working,.

Owens & Minor Reports Third Quarter 2023 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2023 on Friday, November 3, 2023, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:00 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All intere.

Owens & Minor Announces Third Quarter 2023 Earnings Release Date and Conference Call

RICHMOND, Va.--(BUSINESS WIRE)--The Owens & Minor Foundation today shared its achievements over the past year in delivering on its efforts to help build healthier communities.

The Owens & Minor Foundation Provides Update on ESG Initiatives and Teammate Engagement

Investors need to pay close attention to Owens & Minor (OMI) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Owens & Minor (OMI) Stock?

Owens & Minor (OMI) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.76 per share a year ago.

Owens & Minor (OMI) Surpasses Q2 Earnings and Revenue Estimates

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: Consolidated revenue of $2.56 billion Net loss per common share of $(0.37) and adjusted net income per common share of $0.18 $49.3 million in debt pay down and $269 million reduction in net debt “The second quarter of 2023 shows a continuation of our Patient Direct segment's exceptional performance, with another quarter o.

Owens & Minor Reports Second Quarter 2023 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the second quarter of 2023 on Friday, August 4, 2023, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interes.

Owens & Minor Announces Second Quarter 2023 Earnings Release Date and Conference Call

I've not invested in Owens & Minor for a long time, following a 50% drop in share price and a neutral "HOLD" rating. The company has been underperforming for years, with most analysts recommending a "HOLD" stance. Despite its troubled position, I believe Owens & Minor may have upside potential and will continue to provide semi-annual updates.

Potential Turnaround In Owens & Minor (Rating Upgrade)

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services, announced today that Ed Pesicka, the Company's President and CEO, and Jonathan Leon, the Company's SVP, Corporate Treasurer, will be hosting one-on-one meetings with investors at the UBS Healthcare Services Conference in Chatham, Massachusetts on Tuesday, June 27, 2023. About Owens & Minor.

Owens & Minor to Participate in UBS Healthcare Services Conference on Tuesday, June 27, 2023

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services, announced today that Ed Pesicka, the Company's President and CEO, and Alex Bruni, the Company's Chief Financial Officer, will be participating in a webcasted fireside chat at 1:00 p.m. Eastern Daylight Time on Tuesday, May 9, 2023 at BofA Securities' 2023 Health Care Conference in Las Vegas, N.

Owens & Minor to Present at the BofA Securities 2023 Health Care Conference on Tuesday, May 9, 2023

Owens & Minor has raised the full-year guidance after a softer first quarter. This kind of earnings stabilization is welcomed after leverage concerns came into play amidst a disastrous 2022 including an expensive deal being pursued.

Owens & Minor - Not A Minor Jump

Owens & Minor Inc. (NYSE:OMI ) Q1 2023 Earnings Conference Call May 5, 2023 8:30 AM ET Company Participants Edward Pesicka - President, Chief Executive Officer Alexander Bruni - Executive Vice President, Chief Financial Officer Jackie Marcus - Alpha IR Group Conference Call Participants Kevin Caliendo - UBS Michael Cherny - Bank of America Daniel Grosslight - Citi Eric Coldwell - Baird John Stansel - JP Morgan Operator Welcome to the Owens & Minor first quarter 2023 earnings call. All lines have been placed on mute to prevent any background noise.

Owens & Minor (OMI) Q1 2023 Earnings Call Transcript

Owens & Minor (OMI) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.09 per share. This compares to earnings of $0.96 per share a year ago.

Owens & Minor (OMI) Beats Q1 Earnings and Revenue Estimates

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2023. Key Highlights: Consolidated revenue of $2.5 billion in the first quarter Net loss per common share of $(0.32) and adjusted net income per common share of $0.05 in the first quarter $158 million of operating cash flow generated in the first quarter $117 million in debt pay down 2023 outlook reflects strong financial performance in the Patient Direct se.

Owens & Minor Reports First Quarter 2023 Financial Results

Belden

Greif

Manulife Financial

ArcBest

Comerica

Methode Electronics

In a time where tech and biotech stocks are all the rage and dominate the news cycle, it might be tempting to overlook ripe opportunities in the value investing universe. Value stocks tend to be solid, mature businesses that offer investors an opportunity to reap out sized gains.

News for Owens & Minor Stock (OMI)